Most of the point mutations occur at specific arginine residues: the R132 position in IDH1 and the R140/R172 positions in IDH2. Some of these variants can be detected with the use of immunohistochemistry and mutation-specific antibodies, displaying the mosaicism for IDH mutations in central cartilaginous tumours (Fig. 1). Here, IDH1 is linked to neoplasm.